BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34830791)

  • 1. Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer.
    Chaloupka M; Stoermer L; Apfelbeck M; Buchner A; Wenter V; Stief CG; Westhofen T; Kretschmer A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis.
    Kretschmer A; Bischoff R; Chaloupka M; Jokisch F; Westhofen T; Weinhold P; Strittmatter F; Becker A; Buchner A; Stief CG
    World J Urol; 2020 Dec; 38(12):3075-3083. PubMed ID: 32130477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?
    Chaloupka M; Figura F; Weinhold P; Jokisch F; Westhofen T; Pfitzinger P; Bischoff R; Magistro G; Strittmatter F; Becker A; Ormanns S; Schlenker B; Buchner A; Stief CG; Kretschmer A
    World J Urol; 2021 May; 39(5):1431-1438. PubMed ID: 32601983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matter of size? Health-related quality of life after radical prostatectomy for patients with giant prostates.
    Westhofen T; Buchner A; Schlenker B; Becker A; Chaloupka M; Bischoff R; Stief CG; Kretschmer A
    Prostate; 2021 Jun; 81(8):443-451. PubMed ID: 33878204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
    Westhofen T; Bensel M; Schlenker B; Becker A; Stief CG; Kretschmer A; Buchner A
    Prostate; 2023 Oct; 83(14):1313-1322. PubMed ID: 37394751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life.
    Westhofen T; Buchner A; Schlenker B; Becker A; Li M; Belka C; Stief CG; Schmidt-Hegemann NS; Kretschmer A
    J Urol; 2021 Nov; 206(5):1192-1203. PubMed ID: 34184923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Preoperative LUTS on Health-related Quality of Life Following Radical Prostatectomy: A Propensity Score Matched Longitudinal Study.
    Westhofen T; Feyerabend E; Buchner A; Schlenker B; Becker A; Eismann L; Rodler S; Jokisch F; Stief CG; Kretschmer A
    Urology; 2024 Apr; ():. PubMed ID: 38679296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.
    Kretschmer A; Grimm T; Buchner A; Jokisch F; Ziegelmüller B; Casuscelli J; Schulz G; Stief CG; Karl A
    Eur Urol Focus; 2020 Jul; 6(4):704-710. PubMed ID: 30853603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
    Pompe RS; Tian Z; Preisser F; Tennstedt P; Beyer B; Michl U; Graefen M; Huland H; Karakiewicz PI; Tilki D
    Eur Urol Focus; 2017 Dec; 3(6):615-620. PubMed ID: 28869202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
    Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
    BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
    J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Controversy and Developments Regarding the Cytoreductive Prostatectomy for Oligometastatic Prostate Cancer.
    Tian Y; Mao Y; Tang Z; Hu M
    Technol Cancer Res Treat; 2023; 22():15330338231216011. PubMed ID: 38105493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
    Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
    World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
    Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
    Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy.
    Stember DS; Nelson CJ; Mulhall JP
    J Sex Med; 2013 Aug; 10(8):2101-7. PubMed ID: 23679104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.